Sight Diagnostics

company

About

Blood diagnostics company that uses machine vision and AI to transform health systems and outcomes through fast and accurate blood testing.

  • Tel Aviv,Tel Aviv,Israel
  • 101 - 250

Details

Last Funding Type
Series A
Last Funding Money Raised
$6M
Industries
Artificial Intelligence,Computer Vision,Health Care,Health Diagnostics,Machine Learning,Medical,Medical Device
Founded date
Jan 1, 2011
Number Of Employee
101 - 250
Operating Status
Active
Legal Name
Sight Diagnostics Inc.

Sight Diagnostics is a blood diagnostic company that combines machine vision and AI to improve health through fast, convenient and accurate diagnostics. Developed over almost a decade of research, Sight’s technology combines the latest innovations in blood sample preparation, optics, chemistry, biology, physics and computer science.

Sight’s first product, Parasight*, has diagnosed malaria in close to 1 million tests across 24 countries. Sight OLO, Sight’s latest FDA 510(k) cleared blood analyzer, digitizes blood with only 2 drops of a finger prick or venous sample and provides lab-grade Complete Blood Count results in minutes. Sight has growing offices in the UK, the US and Israel, and commercial footprint on 5 continents.

*Note: Parasight is not available for sale in the US and did not receive FDA clearance for use in the US.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$123.80M
Sight Diagnostics has raised a total of $123.80M in funding over 2 rounds. Their latest funding was raised on Aug 5, 2020 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 5, 2020 Series D $71M 6 Koch Disruptive Technologies Detail
Feb 14, 2019 Series C $27.80M 6 Longliv Ventures Detail
Sep 1, 2016 Series B $16M 3 Detail
Nov 1, 2014 Series A $6M 4 Detail
Aug 1, 2011 Seed $3M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
12
Sight Diagnostics is funded by 12 investors. Koch Disruptive Technologies and OurCrowd are the most recent investors.
Investor Name Lead Investor Funding Round
Koch Disruptive Technologies Yes Series D
OurCrowd Series D
Clal Biotechnology Industries Series D
GO CAPITAL Series D
Longliv Ventures Series D
New Alliance Capital Series D
Jack Nicklaus II Series C
Steven Esrick Series C
GEOC Series B
Emery Capital Series A

Employee Profiles

Number of Employee Profiles
4
Sight Diagnostics has 4 current employee profiles, including Executive Daniel Levner
Executive
Board member